Retail sale of pharmaceutical products
AMMELGOEI AS
Revenue 2025
NOK 341,000
Operating profit
NOK −863,000
Equity
NOK 18.6m
Incorporated
2023
Share capital
NOK 60,000
Key figures · 2025
Current ratio
102.14
Equity ratio
99.0%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -253.3% | |
| Net margin (%%) | 491.9% | |
| Return on assets (%%) | -4.6% | |
| Likviditet | ||
| Current ratio | 102.14 | |
| Working capital | 18.1m | |
| Soliditet | ||
| Equity ratio (%%) | 99.0% | |
| Debt-to-equity ratio | 0.01 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.